Φαρμακευτική βιομηχανία

This page is also available in:

  • Εγκριθείσα on 10/06/2009
    Έγγραφα αναφοράς
    INT/471-EESC-2009-01-01-1024
    Workers - GR II
    Italy
    Plenary session number
    454
    -
    EESC opinion: Pharmacovigilance – Community code relating to medicinal products for human use
  • Εγκριθείσα on 10/06/2009
    Έγγραφα αναφοράς
    INT/470-EESC-2009-01-01-1023
    Employers - GR I
    Malta
    Plenary session number
    454
    -
    EESC opinion: Pharmacovigilance – Community Regulation – medicinal products for human and veterinary use
  • Εγκριθείσα on 10/06/2009
    Έγγραφα αναφοράς
    INT/475-EESC-2009-01-01-1025
    Workers - GR II
    Italy
    Plenary session number
    454
    -
    EESC opinion: Medicinal products for human and veterinary use - European Medicines Agency
  • Εγκριθείσα on 10/06/2009
    Έγγραφα αναφοράς
    INT/469-EESC-2009-1022
    Civil Society Organisations - GR III
    Germany
    Plenary session number
    454
    -
    EESC opinion: Medicinal products for human use – Community code
  • Έγγραφα αναφοράς
    INT/478-EESC-2009-01-01-1456
    Employers - GR I
    Netherlands
    Plenary session number
    456
    -
    EESC opinion: Des médicaments sûrs et innovants
  • Conference in the framework of the Belgian presidency of the Council of the European Union

    The Civil Society Organisations' Group will organise this conference in partnership with the Centre Hospitalier Universitaire de Liège and the Hôpital Citadelle. This event is an in-person conference that will be live streamed. Registration for in-person participation will open shortly.

  • Published in
    28 pages

    On 31 March 2022, the European Economic and Social Committee (EESC) held a high-level conference on Health challenges in the EU in the pandemic context.

  • Published in
    8 pages

    Following the publication of the European Commission's Update to the New Industrial Strategy, the European Economic and Social Committee (EESC) has been carrying out a series of activities to fulfil its role of representing the views of organised civil society. A key event in this process has been a conference held on 17 June 2021, from 2.30 to 6 p.m., on Updated industrial strategy: towards a more resilient and strategically autonomous EU industry.